Inve India ▾

Camlin Fine share price & results

Camlin Fine· Chemicals· Commodities

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Global maker of antioxidant blends and vanillin, built on integrated phenol-to-catechol chemistry.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue520 ₹ crore+27.5% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin1.8 %−3.2 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit-34.0 ₹ crore—Quarterly, as filedQuarter to Jun 2026Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown.
Return on equity-2.67 %+18.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin1.16 %+2.3 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)9.36 %−6.3 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

0 of 14 judged targets kept · 13 open · verdicts reflect calls analysed to Q1 FY27.

Camlin Fine management guidance track record on Inve: 27 targets tracked across analysed earnings calls (0 achieved, 14 missed, 13 open).

TargetOriginal wordingSaidLatest callVerdict
Blends Business Growth Rate20% per year for the next couple of years
Call transcript, Q2 FY25 · 11 Nov 2024		Q2 FY25Q1 FY27:Historical promise, missed in FY26. Focus has shifted to new FY27 targets for the broader 'Specialty Ingredients' segment.
Call transcript, Q1 FY27 · 11 Aug 2026		Missed
Vanillin Volume4,000 metric tons in FY27
Call transcript, Q3 FY26 · 13 Feb 2026		Q3 FY26Q1 FY27:So basically, we had guided for 3,600 to 4,000 and now we are saying 3,000 around 3,000. The change is due to a slower ramp-up of ethyl vanillin for quality assurance.
Call transcript, Q1 FY27 · 11 Aug 2026		Revised Down
Blends Business Growth25% growth over FY26
Call transcript, Q3 FY26 · 13 Feb 2026		Q3 FY26Q1 FY27:Management guided for 20-30% growth in the Specialty Ingredients segment for FY27, which includes the blends business, keeping the original target in range.
Call transcript, Q1 FY27 · 11 Aug 2026		On Track

Source: Inve Guidance Tracker for Camlin Fine · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

14 of Camlin Fine's 27 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 24 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹83.75 +0.56% · +₹0.47

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −57.2% 1Y

₹100₹150₹200Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 10 Nov 2025Q3 FY26 — 13 Feb 2026Q4 FY26 — 26 May 2026Q1 FY27 — 11 Aug 2026

1Y: ₹195.73 on 24 Oct 2025 → ₹83.75. High ₹201.32 (29 Oct 2025), low ₹80.53 (23 Oct 2026).

Previous close
₹83.28
Market cap
₹1.6k Cr
52-week range
₹80.53 – ₹201.32
One year
−57.32%
Price to earnings (FY ending Mar 2026)
43.24×
Return on equity (TTM to Jun 2026)
-2.67%

Overview

Symbol
NSE:CAMLINFINE
Sector
Chemicals
Industry
Commodities
Exchange
NSE
Currency
INR

What Camlin Fine does

Based on the company's own presentations, annual report and earnings calls.

Camlin Fine Sciences manufactures specialty chemicals across four lines: antioxidants (Straights) and forward-integrated antioxidant blends used to extend shelf life in food, feed and pet food; performance chemicals derived from hydroquinone and catechol used in petrochemicals, dyes, polymers and agrochemicals; and aroma ingredients, chiefly vanillin and ethyl vanillin, sold into food, flavours & fragrances and pharma. The company runs a vertically integrated chemistry chain (phenol into hydroquinone/catechol into downstream derivatives), captively consuming intermediates to feed its own Straights, Performance Chemicals and Aroma Ingredients businesses. It operates through regional units in India, Mexico, Brazil and North America, plus recently acquired natural-ingredients businesses Vitafor and Vinpai (France), serving customers across food & beverage, animal nutrition, pharmaceuticals, agrochemicals and personal care industries worldwide.

Segments

  • Specialty Ingredients (Straights)
  • Specialty Ingredients (Value Added Blends)
  • Performance Chemicals
  • Aroma Ingredients
Global manufacturing facilities
8
Application laboratories
7
R&D centres
2
Country presence
80+
Integrated global production capacity
49,000+
Product range
100+ diversified product offerings
Company website

How the price took the results

close before → close after

Q1 FY27
+0.9%
11 Aug
Q4 FY26
−1.0%
26 May
Q3 FY26
−2.1%
13 Feb
Q2 FY26
−3.9%
10 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Camlin Fine

Free account: one company. Everything above stays public.

Write why you follow Camlin Fine and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Chemicals companies

All Chemicals companies → · Chemicals earnings growth →

Learn to analyse Camlin Fine

Guides on how to read this kind of business and the numbers that matter.